Cosmos Health Inc. (COSM)

Nasdaq: COSM · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Thessaloniki, GR · filing with the SEC since 2009

Full chart Alerts Compare

Grade4.5

◀ Past 2.3● Present 4.8▶ Future 6.0

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$65.3M+19.9%

Net income-$19.1M-18.3%

Earnings per share$-0.63+46.2%

Operating cash flow-$8.4M-9.5%

Cash$715,674+127.1%

Debt$3.8M-8.1%

Shareholders’ equity$18.4M-24.9%

Shares, diluted30.3M+58.2%

Return on equity-103.9%

The recordfrom its filings

Filings in 202659

Newest filingNov 12 · SCHEDULE 13G/A

Annual reportApr 15, 2026

Quarterly reportAug 18, 2026

Next report due10-Q by Nov 14

Insider sales, 12 months$0.00

Insider buys, 12 months$1.7M

Patents grantedn/a

Filer categoryNon-accelerated filer<br>Smaller reporting company

Trailing twelve months to Jun 2026Revenue $73.7MNet income -$24.4MCash from operations -$9.8Mthe four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

16171819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Nov 10, 2026 · SEC EDGAR · Form 8-K/A

Current report, amended

Open the filing on sec.gov

Nov 10, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 30, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 29, 2026 · SEC EDGAR · Form SCHEDULE 13G

Large holder notice

Open the filing on sec.gov

Oct 22, 2026 · SEC EDGAR · Form 8-K

Results released

Open the filing on sec.gov

Oct 16, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 9, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Aug 20, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Aug 18, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

Cosmos Health Inc. is classed by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries (industry code 5122), based in Thessaloniki, GR. Wholesale was 91% of fiscal 2025 revenue.

Newest on the record

Large holder update, amended on Nov 12. Before it, current report, amended on Nov 10.

What is due next

The 10-Q for the period to Sep 30, 2026, due by Nov 14, 2026.

About COSM

Cosmos Health Inc. is classed by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries (industry code 5122), based in Thessaloniki, GR. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $65 million and a loss of $19 million (its filed statements).

IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries

HeadquartersThessaloniki, GR

Business modelDistribution business

ExchangeNasdaq

Filing since2009

Fiscal year endsDec 31

SEC number (CIK)1474167

Peers on fileZSTK, MEDS, HKPD, HWH

Who runs it

Financial performance

In fiscal 2025 Cosmos Health’s revenue was $65.27 million, up 19.9% from $54.43 million the year before. It made a net loss of $19.14 million.

Annual report, filed Apr 15, 2026.

Financial statements

The grade

Cosmos Health grades 4.5 of 10 against its own industry, the 10 companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries. Eight of the nine metrics are read as filed and one is an SI estimate, each with its reasoning.

◀ Past2.3

● Present4.8

▶ Future6.0

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton COSM · research, not advice